| PJFZX | RGAFX | PJFZX / RGAFX | |
| Total Expense Ratio | 0.69 | 0.34 | 203% |
| Annual Report Gross Expense Ratio | 0.69 | 0.34 | 203% |
| Fund Existence | 30 years | 24 years | - |
| Gain YTD | 1.199 | 6.901 | 17% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.28B | 361B | 2% |
| Annual Yield % from dividends | 0.00 | 0.46 | - |
| Returns for 1 year | -1.49 | 6.45 | -23% |
| Returns for 3 years | 32.60 | 46.09 | 71% |
| Returns for 5 years | 1.78 | 17.48 | 10% |
| Returns for 10 years | 152.94 | 117.96 | 130% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PHPIX | 41.53 | N/A | N/A |
| ProFunds Pharmaceuticals UltraSector Inv | |||
| DGAGX | 34.39 | N/A | N/A |
| BNY Mellon Appreciation Investor | |||
| TSMVX | 30.88 | N/A | N/A |
| Transamerica Small/Mid Cap Value I2 | |||
| AFCSX | 19.38 | N/A | N/A |
| American Century Focused Intl Gr I | |||
| CSXRX | 61.95 | N/A | N/A |
| Calvert US Large Cap Core Rspnb Idx R6 | |||